State of Ohio Update
The State Board of Pharmacy Files New Compounding Rules
After considerable communication and negotiation back and forth with the Ohio State Medical Association and many different medical specialty societies, the Pharmacy Board has changed it proposed compounding rules to address several physician concerns.
As proposed, now the new compounding rule will
- exempt drug reconstitution,
- exempt drug device preparation,
- exempt drug dilution (when administered one hour after preparation).
- allow physicians to prepare buffered lidocaine under the immediate-use rule and, for buffered lidocaine only, physicians can compound 12-hours in advance of using the lidocaine and NOT have to place a patient specific label on the compounded preparation.
The rule was also changed to amend the record-keeping rules to make them slightly less onerous.
Attached is a PDF of the filed rules.
Details on the filing are available at http://www.registerofohio.state.oh.us/
Opioid Dispensing Continues to Fall – Down 41% over Past 6 Years
- OARSS usage dramatically increased in the past 12 months from 90 to 142 million patient reports
- SB 23, “Heartbeat Bill” received considerable press coverage as it passed the Ohio Senate this week. Senator Stephanie Kunze (R-Hilliard) and 3 Republican colleagues joined all Democrats in opposition. The bill still contains criminal liability provisions for physicians. The bill is expected to be considered, and passed, by the House of Representatives in the coming weeks. The Senate President is saying the bill is likely to be challenged and may end up at the US Supreme Court.
- Healthcare Value. The House Health Committee held a hearing this week around issue of “increasing value” in healthcare by promoting competition. While no bills were being considered, legislators discussed issues like price transparency, health savings accounts, telemedicine, alternative health clinics, and patient access to information.